Radiation before surgery for brain metastases from solid tumors
Tests radiosurgery given before surgery in adults with brain metastases.
Key facts
- Who runs it
- Regina Elena Cancer Institute
- Where
- Italy1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
- Status
- Recruiting
- People taking part
- 98 people, planned
- Started
- 26 Sept 2024
- Expected to end
- 26 Sept 2029
- Type of study
- Interventional
- Treatments tested
- Treatment based on stereotactic radiosurgery
- Record updated
- 28 May 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with brain metastases from solid tumors (cancer that has spread to the brain) that can be removed by surgery. They get radiation of 27 Gy in 3 sessions before surgery.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- One brain metastasis of 3 cm (1.2 in) or more, with or without symptoms, or one with symptoms of 2 cm (0.8 in) up to under 3 cm (1.2 in), that surgery can remove. Up to 3 more small lesions treatable by radiosurgery are allowed. No need for urgent surgery for nerve symptoms or rising pressure in the skull. ECOG performance status 2 or lower, Karnofsky Performance Status 60 or higher. Expected to live more than 3 months. Fit enough for surgery (ASA score 3 or lower) and able to have brain MRI with and without contrast dye.
Main reasons for not taking part
- Reasons that rule out radiotherapy
- Pregnancy
- Not able to follow the study procedures or fill out the questionnaires
- Not able to have a brain MRI with contrast dye
- Urgent need for surgery
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- patients with single metastatic brain lesions with a diameter of ≥ 3 cm symptomatic / asymptomatic or with symptomatic brain lesions ≥ 2 cm < 3 cm that are surgically resectable, without or in the presence of max 3 small synchronous lesions amenable to radiosurgery treatment
- no urgent surgical indication for neurological symptoms or worsening intracranial hypertension
- age ≥ 18 years
- performance status according to the Eastern Cooperative Oncology Group (ECOG) scales ≤ 2
- Karnfosky Performance Status ≥ 60
- life expectancy greater than 3 months
- patients assessed as suitable for surgery (ASA score ≤ 3) and in the absence of contraindications to undergoing brain MRI examination without and with contrast medium
- ability to understand and willingness to sign a written informed consent document
Who cannot take part
- contraindications to radiotherapy treatment
- pregnancy
- inability to follow the procedures, to fill out the questionnaires
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this study, the possibility of performing a preoperative neoadjuvant radiotherapy dose of 27 Gy fractionated in 3 sessions is explored, to maximize the biological effect of the treatment, in patients affected by solid tumors, in particular lung, breast and melanoma, in which brain metastases have arisen, the incidence of which is constantly increasing in relation to the improvements in oncological therapies and the consequent increase in patient survival. It was demonstrated that postoperative stereotactic radiosurgery with this fractionation was effective in improving local disease control at 1 year compared to single-dose stereotactic radiosurgery (91% vs 77%) and in reducing the risk of radionecrosis for metastatic brain lesions of size.
The group in the trial
- Patients with brain metastasesTreatment being tested
Patients with single metastatic brain lesions with a diameter ≥ 3 cm symptomatic or asymptomatic or with symptomatic brain lesions ≥ 2 cm \< 3 cm that are surgically resectable, without or in the presence of a maximum of 3 small synchronous lesions amenable to radiosurgery treatment, will undergo radiation treatment of 27 Gy in three fractions (9 Gy per fraction) on alternate days; If other lesions are present, up to a maximum of 3 lesions and a total volume of 35 cc, these will be treated with radical stereotactic radiosurgery according to guidelines
Treatment: Treatment based on stereotactic radiosurgery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prospective Clinical Study on the Efficacy of the Association of Fractionated SRS and Subsequent Surgery in Patients With Brain Metastases
- Plain-language title
- Radiation before surgery for brain metastases from solid tumorsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 28 May 2025